Image Guided Radiotherapy Market
Image Guided Radiotherapy Market Forecasts to 2030 - Global Analysis By Product (Software, Hardware, Accessories and Service), Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Image Guided Radiotherapy Market is accounted for $2.05 billion in 2023 and is expected to reach $3.34 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Image Guided Radiotherapy (IGRT) is a precise form of radiation therapy that utilizes imaging technology to guide the delivery of radiation to tumours. IGRT enables clinicians to visualize the tumor and surrounding tissues in real-time, allowing for more accurate targeting of radiation and minimizing damage to healthy tissue. This approach enhances treatment effectiveness while reducing side effects. IGRT is particularly valuable for tumours that move during treatment or are located near critical organs, offering improved outcomes and increased patient safety.
According to the American Cancer Society, the burden of cancer worldwide is expected to reach ~28.4 million cases by 2040, increased by 47% from 2020, with greater increases in developing countries due to demographic changes and over 60% of cancer patients undergo some form of radiation therapy as part of their treatment.
Market Dynamics:
Driver:
Rising prevalence of cancer
With cancer incidence rates on the rise, there's an amplified demand for advanced treatment modalities that offer precision and minimal invasiveness. IGRT, leveraging cutting-edge imaging technologies, enables precise tumor targeting while sparing healthy tissues, making it an increasingly preferred option in oncology. This growing demand for more effective and tailored cancer treatments positions IGRT as a pivotal solution, driving its adoption and market growth amidst the expanding landscape of cancer care.
Restraint:
Lack of skilled professionals
The scarcity of trained professionals poses a significant obstacle to the expansion of the Image Guided Radiotherapy (IGRT) market. Successful utilization of IGRT technology necessitates skilled healthcare practitioners proficient in its operation and interpretation. Without an adequate workforce, healthcare facilities may struggle to offer IGRT services, leading to underutilization of IGRT technology and hindering its market growth potential.
Opportunity:
Continuous innovations in radiotherapy equipment
Continuous innovations in radiotherapy equipment enhance treatment precision, efficiency, and patient outcomes. Advanced features such as improved imaging modalities, real-time monitoring, and automated treatment delivery systems increase the accuracy of tumor targeting while minimizing damage to surrounding healthy tissue. These innovations attract healthcare providers seeking state-of-the-art solutions, boosting adoption rates. Additionally, technological advancements enable the development of more compact and cost-effective IGRT systems, expanding accessibility to a broader patient population.
Threat:
High cost of equipment and treatment
The high cost of equipment and treatment in IGRT limits accessibility, particularly in regions with constrained healthcare budgets. The substantial initial investment required for IGRT systems and ongoing treatment expenses can deter healthcare facilities from adopting this technology. Additionally, patients face financial burdens, and healthcare providers encounters challenges in securing reimbursement for IGRT procedures. Consequently, the high cost of equipment and treatment hampers the widespread adoption and utilization of IGRT, impeding market expansion.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the image guided radiotherapy market. While it initially led to disruptions in treatment schedules and a slowdown in installations of new equipment due to healthcare facility closures and reprioritization of resources, there has been a subsequent rebound driven by pent-up demand and a growing emphasis on cancer care. Furthermore, the pandemic has accelerated the adoption of telemedicine and remote monitoring technologies, which could have long-term implications for how IGRT services are delivered and accessed, potentially fostering market growth.
The 3D ultrasound segment is expected to be the largest during the forecast period
The 3D ultrasound segment is estimated to have a lucrative growth. By providing real-time, high-resolution imaging of tumor sites, 3D ultrasound enhances the precision and accuracy of treatment delivery. This technology allows for better visualization of tumor boundaries and surrounding anatomy, enabling oncologists to tailor radiation therapy with utmost precision. Its incorporation into IGRT workflows enhances patient outcomes and treatment efficacy.
The brain tumours segment is expected to have the highest CAGR during the forecast period
The brain tumours segment is anticipated to witness the highest CAGR growth during the forecast period. Utilizing advanced imaging techniques such as MRI, CT, and PET scans, IGRT enables real-time visualization of tumours during treatment, allowing for accurate radiation delivery. This approach enhances treatment efficacy while reducing the risk of side effects. It also facilitates personalized treatment plans tailored to individual patient needs, optimizing outcomes for brain tumor patients.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing cancer incidence and advancements in healthcare infrastructure. Emerging economies such as China and India are key contributors, supported by rising healthcare expenditure and expanding access to advanced treatment modalities. With a favourable regulatory environment and growing awareness about cancer care, the Asia Pacific IGRT market is poised for continued growth.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period, owing to high prevalence of cancer and robust healthcare infrastructure. The United States dominates the market, driven by extensive research and development activities, along with significant investments in healthcare technology. Increasing adoption of advanced imaging technologies and software solutions, coupled with favourable reimbursement policies, propels market expansion. With a focus on precision medicine and patient-centric care, the North American IGRT market is poised for sustained growth and technological advancements.
Key players in the market
Some of the key players profiled in the Image Guided Radiotherapy Market include Siemens Healthineers, Elekta AB, Accuray Incorporated, ViewRay, Inc., Brainlab AG, RaySearch Laboratories, Mevion Medical Systems, C-RAD AB, IBA Dosimetry GmbH, Philips Healthcare, Hitachi Medical Systems, Theragenics Corporation, Nanobiotix and Xstrahl Limited.
Key Developments:
In March 2024, Siemens Healthineers and Varian Medical Systems announced the launch of their Image Guided Radiotherapy (IGR) product. The product helps practitioners provide digital image data for diagnosis, risk stratification, and treatment planning in the early stages of liver cancer detection. The data can also provide guidance and support during care.
In February 2024, Royal Philips, a health technology company, announced the launch of the Azurion neuro biplane system, a new version of its Image Guided Therapy (IGT) platform. The Azurion platform is powered by ConnectOS, a new operating system from Philips that optimizes system integration.
Products Covered:
• Software
• Hardware
• Accessories
• Service
Technologies Covered:
• Cone Beam Computed Tomography (CBCT)
• 3D Ultrasound
• MRI-guided Radiation Therapy (MRI-RT)
• Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
• Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
• Other Technologies
Applications Covered:
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head and Neck Cancer
• Brain Tumours
• Gynaecological Cancer
• Other Applications
End Users Covered:
• Hospitals
• Radiation Therapy Centers
• Cancer Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Image Guided Radiotherapy Market, By Product
5.1 Introduction
5.2 Software
5.2.1 Treatment Planning Software
5.2.2 Image Processing Software
5.2.3 Image Registration Software
5.2.4 Treatment Delivery Software
5.2.5 Quality Assurance Software
5.3 Hardware
5.3.1 Linear Accelerators (LINAC)
5.3.2 X-ray Systems
5.3.3 Ultrasound Systems
5.4 Accessories
5.4.1 IGRT Tables
5.4.2 IGRT Couches
5.4.3 IGRT Markers
5.4.4 IGRT Calibrators
5.4.5 IGRT Immobilization Devices
5.5 Service
5.5.1 Installation Services
5.5.2 Maintenance and Repair Services
6 Global Image Guided Radiotherapy Market, By Technology
6.1 Introduction
6.2 Cone Beam Computed Tomography (CBCT)
6.3 3D Ultrasound
6.4 MRI-guided Radiation Therapy (MRI-RT)
6.5 Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
6.6 Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
6.7 Other Technologies
7 Global Image Guided Radiotherapy Market, By Application
7.1 Introduction
7.2 Prostate Cancer
7.3 Breast Cancer
7.4 Lung Cancer
7.5 Head and Neck Cancer
7.6 Brain Tumours
7.7 Gynaecological Cancer
7.8 Other Applications
8 Global Image Guided Radiotherapy Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Radiation Therapy Centers
8.4 Cancer Research Institutes
8.5 Other End Users
9 Global Image Guided Radiotherapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Siemens Healthineers
11.2 Elekta AB
11.3 Accuray Incorporated
11.4 ViewRay, Inc.
11.5 Brainlab AG
11.6 RaySearch Laboratories
11.7 Mevion Medical Systems
11.8 C-RAD AB
11.9 IBA Dosimetry GmbH
11.10 Philips Healthcare
11.11 Hitachi Medical Systems
11.12 Theragenics Corporation
11.13 Nanobiotix
11.14 Xstrahl Limited
List of Tables
1 Global Image Guided Radiotherapy Market Outlook, By Region (2021-2030) ($MN)
2 Global Image Guided Radiotherapy Market Outlook, By Product (2021-2030) ($MN)
3 Global Image Guided Radiotherapy Market Outlook, By Software (2021-2030) ($MN)
4 Global Image Guided Radiotherapy Market Outlook, By Treatment Planning Software (2021-2030) ($MN)
5 Global Image Guided Radiotherapy Market Outlook, By Image Processing Software (2021-2030) ($MN)
6 Global Image Guided Radiotherapy Market Outlook, By Image Registration Software (2021-2030) ($MN)
7 Global Image Guided Radiotherapy Market Outlook, By Treatment Delivery Software (2021-2030) ($MN)
8 Global Image Guided Radiotherapy Market Outlook, By Quality Assurance Software (2021-2030) ($MN)
9 Global Image Guided Radiotherapy Market Outlook, By Hardware (2021-2030) ($MN)
10 Global Image Guided Radiotherapy Market Outlook, By Linear Accelerators (LINAC) (2021-2030) ($MN)
11 Global Image Guided Radiotherapy Market Outlook, By X-ray Systems (2021-2030) ($MN)
12 Global Image Guided Radiotherapy Market Outlook, By Ultrasound Systems (2021-2030) ($MN)
13 Global Image Guided Radiotherapy Market Outlook, By Accessories (2021-2030) ($MN)
14 Global Image Guided Radiotherapy Market Outlook, By IGRT Tables (2021-2030) ($MN)
15 Global Image Guided Radiotherapy Market Outlook, By IGRT Couches (2021-2030) ($MN)
16 Global Image Guided Radiotherapy Market Outlook, By IGRT Markers (2021-2030) ($MN)
17 Global Image Guided Radiotherapy Market Outlook, By IGRT Calibrators (2021-2030) ($MN)
18 Global Image Guided Radiotherapy Market Outlook, By IGRT Immobilization Devices (2021-2030) ($MN)
19 Global Image Guided Radiotherapy Market Outlook, By Service (2021-2030) ($MN)
20 Global Image Guided Radiotherapy Market Outlook, By Installation Services (2021-2030) ($MN)
21 Global Image Guided Radiotherapy Market Outlook, By Maintenance and Repair Services (2021-2030) ($MN)
22 Global Image Guided Radiotherapy Market Outlook, By Technology (2021-2030) ($MN)
23 Global Image Guided Radiotherapy Market Outlook, By Cone Beam Computed Tomography (CBCT) (2021-2030) ($MN)
24 Global Image Guided Radiotherapy Market Outlook, By 3D Ultrasound (2021-2030) ($MN)
25 Global Image Guided Radiotherapy Market Outlook, By MRI-guided Radiation Therapy (MRI-RT) (2021-2030) ($MN)
26 Global Image Guided Radiotherapy Market Outlook, By Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT) (2021-2030) ($MN)
27 Global Image Guided Radiotherapy Market Outlook, By Computed Tomography (CT) -guided Radiation Therapy (CT-RT) (2021-2030) ($MN)
28 Global Image Guided Radiotherapy Market Outlook, By Other Technologies (2021-2030) ($MN)
29 Global Image Guided Radiotherapy Market Outlook, By Application (2021-2030) ($MN)
30 Global Image Guided Radiotherapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
31 Global Image Guided Radiotherapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
32 Global Image Guided Radiotherapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
33 Global Image Guided Radiotherapy Market Outlook, By Head and Neck Cancer (2021-2030) ($MN)
34 Global Image Guided Radiotherapy Market Outlook, By Brain Tumours (2021-2030) ($MN)
35 Global Image Guided Radiotherapy Market Outlook, By Gynaecological Cancer (2021-2030) ($MN)
36 Global Image Guided Radiotherapy Market Outlook, By Other Applications (2021-2030) ($MN)
37 Global Image Guided Radiotherapy Market Outlook, By End User (2021-2030) ($MN)
38 Global Image Guided Radiotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
39 Global Image Guided Radiotherapy Market Outlook, By Radiation Therapy Centers (2021-2030) ($MN)
40 Global Image Guided Radiotherapy Market Outlook, By Cancer Research Institutes (2021-2030) ($MN)
41 Global Image Guided Radiotherapy Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
